title: I35H4_B16_ACTaPD1a41BB_TCR
organism: Mus musculus
attributes.tag: source_name
attributes.value: skin of body
attributes.tag: tissue
attributes.value: skin of body
attributes.tag: immgent igt_10xlane_id
attributes.value: IGT35
attributes.tag: hashtag number
attributes.value: HT4
attributes.tag: condition detailed_organ
attributes.value: B16_ACTaPD1a41BB
attributes.tag: cite seq
attributes.value: TRUE
attributes.tag: exp name
attributes.value: T cells in B16.gp33 melanoma with adoptive cell therapy and checkpoint blockade
attributes.tag: lab
attributes.value: Goldrath
attributes.tag: organism name
attributes.value: mouse0125
attributes.tag: strain
attributes.value: C57BL/6J
attributes.tag: genetics
attributes.value: P14 and pmel > wt
attributes.tag: Sex
attributes.value: male
attributes.tag: age weeks
attributes.value: 8
attributes.tag: pool of_mice
attributes.value: TRUE
attributes.tag: treat agent
attributes.value: anti PD-1 (clone J43) and anti 4-1BB (clone 3H3); P14 T cells (CD45.1.2) and pmel (CD45.1)
attributes.tag: treat dose
attributes.value: B16.gp33, subcutaneous, at D0; 2.5x10E6 pmel and 2.5x10E6 P14, intravenous, at D7; 200ug anti PD1 and 50ug anti 4-1BB at D9, D11 and D13
attributes.tag: tumor
attributes.value: B16.gp33
attributes.tag: prep description
attributes.value: collagenase I
attributes.tag: organ
attributes.value: skin of body
attributes.tag: organ uberon_id
attributes.value: http://purl.obolibrary.org/obo/UBERON_0002097
attributes.tag: target cells
attributes.value: all T including P14 and pmel
attributes.tag: gating strategy
attributes.value: CD3e+ CD45.2+ enriched with transgenic CD3+ CD45.2- CD8+ CD45.1+ or CD45.1.2+
attributes.tag: mouse comments
attributes.value: ACT/CBI; pool of 10 mice
attributes.tag: cell type
attributes.value: T cells
attributes.tag: geo_loc_name
attributes.value: missing
attributes.tag: collection_date
attributes.value: missing